Back to search

Article

A Novel Cancer-associated Fibroblasts-Related Gene Signature Based on Adjuvant Sorafenib Efficacy for Predicting Recurrence and Immunotherapy Response in Hepatocellular Carcinoma After Hepatectomy

2023-03-30

Abstract excerpt

<h4>Background: </h4> Due to its high recurrence rate, hepatocellular carcinoma (HCC) has a poor prognosis after hepatectomy. An effective model to predict postoperative recurrence and identify high-risk patients is essential. Recent studies have revealed the important role of cancer-associated fibroblasts (CAFs) in predicting HCC prognosis. However, the prognostic value of CAFs-related gene signature in HCC recur...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7eb5ccb9-05b2-59c0-82ff-4870ec368704
DOI
10.21203/rs.3.rs-2745988/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Novel Cancer-associated Fibroblasts-Related Gene Signature Based on Adjuvant Sorafenib Efficacy for Predicting Recurrence and Immunotherapy Response in Hepatocellular Carcinoma After HepatectomyDOI 10.21203/rs.3.rs-2745988/v1
Select a neighboring publication to make it the new centre.